CAS: 135-73-9; 2-Bromo-4'-Phenylacetophenone

该化合物是有机化合物,其特征为联苯结构,具有溴己酮功能组,该化合物一般是固体或晶体物质,由于溴原子的存在,可参与核生殖性替代反应,因此具有反应性,因此具有反应性.Ketone功能组有助于其电子生殖性,使其成为有机合成中的有用中间体.该化合物经常用于各种制药和农用化学品制作过程中.该化合物一般在标准条件下保持稳定,但由于其潜在毒性和再活性,可能需要小心处理.与许多有机化合物一样,必须考虑其在有机溶剂中的溶解性及其在不同pH条件下的行为.应参考安全数据表,以了解具体的处理和储存准则,以及与接触有关的潜在危险.

结构式图片

相似化合物

4072-67-7 635-84-7 92-91-1

欧盟法规

ECHA物质C&L通报REACH预注册

上下游产品

biphenyl-4-acetaldehyde biphenyl 2-Bromoacetyl bromide 1-(4-phenyl-phenyl)-1-ethanol 2-biphenyl-4-yl-indolizine 3-hydroxy-1-(4-phenyl-phenacyl)-pyridinium; bromide 2-([1,1'-biphenyl]-4-yl)imidazo[1,2-a]pyridine 7-methyl-2-(biphenyl-4-yl)imidazo[1,2-a]pyridine

合成工艺路线路线简述

    联苯单乙酮置于溴,溶剂黄146体系中,化学反应生成2-溴-4-苯基乙酰苯
    参考文献:能够诱导细胞凋亡的磺酰化 1,2,3-三唑掺入苯磺酰胺对碳酸酐酶 Ix 的选择性抑制
    标题:能够诱导细胞凋亡的磺酰化 1,2,3-三唑掺入苯磺酰胺对碳酸酐酶 Ix 的选择性抑制
    摘要:抽象的 为了寻找具有细胞凋亡诱导特性的选择性碳酸酐酶 (Ca) Ix 抑制剂,我们设计并合成了 4-和 3-(5-芳基-(4-苯基磺酰基)-1 H-1,2,3-三唑的两个子集-1-基)苯磺酰胺.检测所有化合物对人碳酸酐酶 (Hca) 亚型 I,Ii,Iv 和 Ix 的抑制作用.大多数合成化合物对 Hca I 和 Hca Iv 亚型有微弱的抑制作用.与三取代类似物不同,许多四取代苯磺酰胺对 Hca Ii 异构体表现出低纳摩尔抑制.所有目标化合物对肿瘤相关异构体 Hca Ix 均表现出非常好的抑制特性,K 值范围为 16.4 至 66.0 Nm.测定了一些 Hca Ix 的选择性和有效抑制剂对山羊睾丸细胞的体外凋亡诱导.化合物10D和10H显示出有趣的细胞凋亡诱导潜力.本研究可能为设计基于具有细胞凋亡干扰的 Hca 抑制剂的新型抗癌药物的策略提供见解.
    Doi:10.1080/14756366.2022.2077333

    海关参考信息

    专利信息


    专利号:WO-9837078-A1
    优先权日:1997-02-20
    标题 :Solid phase and combinatorial synthesis of substituted thiophenes and of arrays of substituted thiophenes
    发明人:DOERWALD FLORENCIO ZARAGOZA
    权利人:NOVO NORDISK AS
    摘要:A solid phase method for the synthesis of a plurality of differently substituted thiophenes with a wide variety of side-chain substituents as compounds of potential therapeutic interest. The thiophenes are prepared by reaction of a substrate-bound primary or secondary amine with a thiophosgene equivalent and reaction of the resulting intermediate with an acceptor-substituted acetonitrile in the presence of a base. Alkylation with an appropriate alkyl halide, followed by Thorpe-Ziegler-cyclization yields differently substituted, support-bound 3-aminothiophenes. These may be screened on the substrate or cleaved from the substrate and then screened in solution. Alternatively, the resin-bound 3-amino thiophenes or the synthetic intermediates can be subjected to further synthetic transformations (N-acylation, reduction) on the support, which permits the preparation of further therapeutically interesting compounds. The efficient synthesis of a wide variety of thiophenes using automated synthesis technology of the present method makes these compounds attractive candidates for the generation and rapid screening of diverse thiophene-based libraries. The method disclosed here provides an easy and fast access to highly diverse heterocyclic compounds of therapeutic interest, amenable to automatization.

    专利号:US-6136984-A
    优先权日:1996-04-22
    标 题 :Solid phase and combinatorial synthesis of substituted thiophenes and of arrays of substituted thiophenes
    发明人:DOERWALD FLORENCIO ZARAGOZA
    权利人:NOVO NORDISK AS
    摘要:A solid phase method for the synthesis of a plurality of differently substituted thiophenes with a wide variety of side-chain substituents as compounds of potential therapeutic interest is disclosed. The thiophenes are prepared by acylation of a substrate-bound primary or secondary amine with cyanoacetic acid and reaction of the resulting cyanoacetamide with an isothiocyanate in the presence of a base. Alkylation with an appropriate alkyl halide, followed by Thorpe-Ziegier-cyclization yields differently substituted, support-bound 3-aminothiophenes. These may be screened on the substrate or cleaved from the substrate and then screened in solution. Alternatively, the resin-bound 3-amino thiophenes or the synthetic intermediates can be subjected to further synthetic transformations (N-acylation, reduction) on the support, which permits the preparation of further therapeutically interesting compounds. The efficient synthesis of a wide variety of thiophenes using automated synthesis technology of the present method makes these compounds attractive candidates for the generation and rapid screening of diverse thiophene-based libraries. The method disclosed here provides an easy and fast access to highly diverse heterocyclic compounds of therapeutic interest, amenable to automatization.

    专利号:US-6933303-B2
    优先权日:2001-10-19
    标 题:Heteroaryl-fused nitrogen heterocycles as therapeutic agents
    发明人:MJALLI ADNAN M M; ANDREWS ROBERT C; XIE RONGYUAN; YARRAGUNTA RAVINDRA R; REN TAN
    权利人:TRANSTECH PHARMA INC
    摘要:This invention provides compounds which are useful as inhibitors of protein tyrosine phosphatases (PTPases). As inhibitors of PTPases, the compounds of the invention are useful for the management, treatment, control and adjunct treatment of diseases mediated by PTPase activity. Such diseases include type I diabetes, type II diabetes, immune dysfunction, AIDS, autoimmunity, glucose intolerance, obesity, cancer, psoriasis, allergic diseases, infectious diseases, inflammatory diseases, diseases involving the modulated synthesis of growth hormone or the modulated synthesis of growth factors or cytokines which affect the production of growth hormone, or Alzheimer's disease.

    专利号:US-8906915-B2
    优先权日:2009-12-17
    标 题:Compounds, compositions, and methods for controlling biofilms
    发明人:DE KEERSMAECKER SIGRID; DE VOS DIRK; ERMOLATEV DENIS; STEENACKERS HANS; VAN DER EYCKEN ERIK; VANDERLEYDEN JOZEF; SAVALIYA BHARAT S
    权利人:DE KEERSMAECKER SIGRID; DE VOS DIRK; ERMOLATEV DENIS; STEENACKERS HANS; VAN DER EYCKEN ERIK; VANDERLEYDEN JOZEF; SAVALIYA BHARAT S; UNIV LEUVEN KATH
    摘要:The invention relates to substituted 2-aminoimidazoles and their imidazo[1,2-a]pyrimidinium salts precursors being active against biofilm formation. The invention also relates to imidazo[1,2-a]pyrimidinium salts bearing an azidoalkyl substituent, and to substituted 2-aminoimidazoles wherein the amino group bears a terminal heterocyclic group such as a triazolyl group which are formed through azide-alkyne Huisgen cycloaddition starting from said imidazo[1,2-a]pyrimidinium salts bearing an azidoalkyl substituent. The invention also relates to a class of N-(azidoalkyl)pyrimidin-2-amines useful as starting materials for the synthesis of said imidazo[1,2-a]pyrimidinium salts bearing an azidoalkyl substituent. The invention also relates to antimicrobial compositions that include a microbial biofilm formation inhibiting amount of such substituted 2-aminoimidazoles or imidazo[1,2-a]pyrimidinium salts in combination with excipients. Methods for inhibiting or controlling microbial biofilm formation in a plant, a body part of a human or an animal, or a surface with which a human or an animal may come into contact are also disclosed.

    专利号:WO-9740034-A1
    优先权日:1996-04-22
    标题:Solid phase and combinatorial synthesis of substituted thiophenes and of arrays of substituted thiophenes

    专利号:JP-2000508664-A
    优先权日:1996-04-22
    标题:Solid-phase and combinatorial synthesis of substituted thiophenes and arrays of substituted thiophenes
    嘉兴市吉拉特化工有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.jlightchem.com
    企业联系电话:0573-82813637;82813639👤
    📞嘉兴市吉拉特化工有限公司 ⚠️参考联系方式
    联系人:魏经理;王经理;叶经理
    电话:0573-82813637;82813639
    手机:13605839392;15857374971;15157377625
    传真:0573-82813637
    邮箱:sales@jlightchem.com
    通信地址: 浙江省嘉兴市大桥镇嘉兴工业园区东塘支路北侧
    邮编: 314006
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    地址:浙江省嘉兴市大桥镇嘉兴工业园区东塘支路北侧
    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
    ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    上海法默生物科技有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.famobiotech.com
    电话: 021-36680027👤
    📞上海法默生物科技有限公司 ⚠️参考联系方式

    销售电话:021-36680027
    邮箱:sales@famobiotech.com
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别 ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    第 1 / 1 页
    现货

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    主要参考文献

    [参考文献]: M Caprou, Et Al. [参考文献]: Rev Med Chir Soc Med Nat Iasi. 1989 Jan-Mar;93(1):175-7.

    合成参考文献


    摘要:Shimada, K., Science of Synthesis Knowledge Updates, (2010) 1, 446.
    摘要:Shimada, K., Science of Synthesis Knowledge Updates, (2010) 1, 432.
    摘要:Aitken, R. A., Science of Synthesis Knowledge Updates, (2018) 3, 319.
    摘要:Collings, J. C., Science of Synthesis Knowledge Updates, (2013) 4, 223.
    摘要:Ayad, T.; Pirat, J.-L.; Virieux, D., Science of Synthesis Knowledge Updates, (2022) 1, 343.
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知